It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...
INR:0819. ludo dice png AbbVie's JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis Vitrakvi, the first "broad-spectrum" anticancer drug that ...